Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px
Organisation › Details

Thuja Capital Healthcare Fund III

On 16 December 2021, Thuja Capital Management, an early stage life sciences investor, announces the final close of its Thuja Capital Healthcare Fund III ("Fund III") at EUR 76M. Fund III is focused on investing in early stage companies that develop novel therapeutics, medical devices (including digital health) or nutraceuticals, based in the Netherlands, Belgium or Germany. The European Investment Fund (EIF), ASR as well as several Dutch and Walloon regional investment agencies are part of a strong base of LPs supporting the fund. In addition, several universities and knowledge institutions, amongst which Sanquin, Utrecht University and UMC, Radboud UMC, Brightlands Maastricht, Delft Enterprises and KU Leuven have backed the fund. The Fund will identify early stage investment opportunities, often still at an academic project/spin-off stage, and work actively with management to develop initial preclinical proof of concept and attract follow-on investment rounds, on its way to realize meaningful healthcare impact. Fund III will build a portfolio of 10-12 investments, comprising promising and impactful Dutch, Belgian and German early-stage ventures. The fund has made three investments to date: Alesta Therapeutics (Leiden, The Netherlands), EsoBiotec (Gosselies, Belgium) and Pan Cancer T (Rotterdam, The Netherlands). *

 

Period Start 2021-12-16 closing, final
  Group Thuja Capital (Group)
Product Industry  healthcare
     
Region Region Utrecht
  Country Netherlands
  Street 40 Yalelaan
  City 3584 CM Utrecht
    Address record changed: 2021-12-23
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 76,000,000 (fund size at final closing (2021) 2021-12-16)
     
    * Document for �About Section�: Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht.
     
   
Record changed: 2022-01-02

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Thuja Capital (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px




» top